Avinger, Inc. (NASDAQ:AVGR) Short Interest Down 23.0% in July

Avinger, Inc. (NASDAQ:AVGR) was the recipient of a large decline in short interest in the month of July. As of July 15th, there was short interest totalling 35,100 shares, a decline of 23.0% from the June 30th total of 45,600 shares. Currently, 2.5% of the company’s shares are short sold. Based on an average daily volume of 18,000 shares, the short-interest ratio is presently 2.0 days.

Wall Street Analyst Weigh In

Separately, StockNews.com assumed coverage on shares of Avinger in a report on Sunday, July 21st. They set a “hold” rating for the company.

Avinger Trading Down 11.8 %

AVGR traded down $0.19 on Friday, reaching $1.42. 974,989 shares of the company traded hands, compared to its average volume of 14,238. Avinger has a one year low of $1.22 and a one year high of $14.00. The firm has a fifty day simple moving average of $1.95 and a two-hundred day simple moving average of $2.85.

Avinger (NASDAQ:AVGR) last announced its quarterly earnings data on Wednesday, May 15th. The medical device company reported ($2.49) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.35) by ($1.14). The company had revenue of $1.86 million for the quarter, compared to the consensus estimate of $2.36 million. On average, research analysts expect that Avinger will post -2.08 EPS for the current year.

Avinger Company Profile

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.